Optimal initial dose of orally administered cyclosporine following intravenous cyclosporine therapy

Transplantation Proceedings

Volumn 37, Issue 10, 2005, Pages 4370-4372

  Ishizawa, T ^a   Sugawara, Y ^a   Ikeda, M ^a   Hasegawa, K ^a   Makuuchi, M ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; TACROLIMUS;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; FEMALE; HEART FAILURE; HUMAN; KIDNEY FAILURE; LINEAR REGRESSION ANALYSIS; LIVER TRANSPLANTATION; LIVING DONOR; MALE; NEUROTOXICITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADMINISTRATION, ORAL; ADULT; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; LIVER TRANSPLANTATION; MIDDLE AGED; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES;

EID: 29544437203     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.11.029     Document Type: Article

References (10)

1. R.W. Busuttil, J.R. Lake Role of tacrolimus in the evolution of liver transplantation Transplantation 77 suppl 2004 S44
2. A. Jain, D. Brody, T. Hamad Conversion to Neoral for neurotoxicity after primary adult liver transplantation under tacrolimus 1 Transplantation 69 2000 172
3. S. Tamura, Y. Sugawara, N. Kishi Conversion to cyclosporine provides valuable rescue therapy for living donor adult liver transplant patients intolerant to tacrolimus a single-center experience at the University of Tokyo Transplant Proc 36 2004 3242
4. Y. Sugawara, M. Makuuchi Technical advances in living-related liver transplantation J Hepatobil Pancreat Surg 6 1999 245
5. H.E. Wilczek, E. Berglin, I. Blohmé The Swedish nationwide experience of converting transplant patients treated with sandimmun to the new galenic formulation Sandimmun-Neoral Transplant Proc 29 1997 280
6. E.A. Mueller, Z. Kallay, J.M. Kovarik Assessment of glomerular filtration rate after multiple administration of a new oral formulation of cyclosporine in clinically stable renal transplant patients Transplant Proc 27 1995 834
7. Y.M. Ku, D.I. Min, M. Flanigan Effect of grapefruit juice on the pharmacokinetics of microemulsion cyclosporine and its metabolite in healthy volunteers does the formulation difference matter? J Clin Pharmacol 38 1998 959
8. Sandimmun Concentrates for Infusion 50 mg/ml in ABPI Medicine Compendium 2005 Surrey, UK: Datapharm Publications, p 2141
9. K. Mahalati, P. Belitsky, I. Sketris Neoral monitoring by simplified sparse sampling area under the concentration-time curve its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation Transplantation 68 1999 55
10. International Neoral Renal Transplantation Study Group Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation Am J Transplant 2 2002 148